Basics Capricor Therapeutics, Inc. Capricor Therapeutics Inc is a clinical stage biotechnology company developing products for the treatment of cardiovascular diseases with a focus on heart failure. IPO Date: March 1, 2007 Sector: Healthcare Industry: Biotech Market Cap: $292.59M Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 3.94% Avg Daily Range (30 D): $0.25 | 3.61% Avg Daily Range (90 D): $0.33 | 4.07% Institutional Daily Volume Avg Daily Volume: .66M Avg Daily Volume (30 D): 1.13M Avg Daily Volume (90 D): 1.88M Trade Size Avg Trade Size (Sh.): 182 Avg Trade Size (Sh.) (30 D): 120 Avg Trade Size (Sh.) (90 D): 132 Institutional Trades Total Inst.Trades: 321 Avg Inst. Trade: $1.31M Avg Inst. Trade (30 D): $3.74M Avg Inst. Trade (90 D): $1.11M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.48M Avg Closing Trade (30 D): $3.74M Avg Closing Trade (90 D): $1.28M Avg Closing Volume: 130.63K     News Sep 25, 2025 @ 3:16 PM Why Capricor Therapeutics Stock Is Surging Today Source: Alex Perry Sep 15, 2025 @ 7:58 PM Shareholders of Capricor Therapeutics, Inc. Should... Source: The Gross Law Firm Sep 14, 2025 @ 8:00 PM CAPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman Llc Sep 14, 2025 @ 1:44 PM CAPR IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR C... Source: Rosen Law Firm Sep 14, 2025 @ 1:27 PM CAPRICOR DEADLINE ALERT: Bragar Eagel & Squire, P.... Source: Bragar Eagel & Squire, P.C. Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.59 $-.57 $-.53 Diluted EPS $-1.59 $-.57 $-.53 Revenue $ 13.39M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -69.98M $ -25.91M $ -24.39M Operating Income / Loss $ -73.41M $ -27.72M $ -24.98M Cost of Revenue $ $ $ Net Cash Flow $ 12.55M $ -5.55M $ 17.51M PE Ratio     Splits Jun 05, 2019:   1:10 Nov 21, 2013:   1:50 Feb 09, 2007:   1:10 Apr 05, 2005:   1:20